Waters Corporation WAT has been continuously making new enhancements to gain momentum in the Liquid Chromatography Mass Spectrometry (LC-MS) market.. This is evident from the fact that the company ...

Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative ...

Waters Corporation has introduced TruView™ LCMS Certified Vials, a new line of low-adsorption sample vials certified for LC/MS/MS analyses where analyte concentrations are on the order of ng/mL or ...

Waters designed the BioAccord System as a fit-for-purpose LC-MS biopharmaceutical solution to deliver rich mass spectrometry data for improved productivity and effective decision-making." ...

Waters Corp. WAT recently announced that its indigenously built ACQUITY UPLC I-Class IVD/Xevo TQ-S micro IVD System has been classified as a U.S. FDA. Waters Secures Regulatory Approvals for LC-MS ...

The Waters SARS-CoV-2 LC-MS Kit (RUO) has been optimized on the ACQUITY™ I-Class Plus System and the Xevo TQ-XS System. It comes in an adaptable automation-friendly format with liquid handling ...

On Tuesday, Jefferies elevated its position on Waters Corporation (NYSE:WAT) stock, a prominent analytical instrument manufacturer, from Hold to Buy. The firm also increased its price target for the ...

On Tuesday, Jefferies elevated its position on Waters Corporation (NYSE:WAT) stock, a prominent analytical instrument manufacturer, from Hold to Buy. The firm also increased its price target for ...

Waters stock poised for gains as LCMS cycle boosts outlook, says Jefferies. Editor Emilio Ghigini. Company News. Editor Emilio Ghigini. Published 10/08/2024, 03:23 AM.